晚发性牛皮关节炎的独特临床模式和管理趋势:来自阿根廷RECCAPSO注册表的数据
Gustavo A Medina1, Maximiliano Fenucci2, Sebastián Magri3
1Rheumatology, Hospital de Clínicas, Buenos Aires University, Buenos Aires, Argentina.
Therapeutic advances in musculoskeletal disease
|July 14, 2025
概括
晚发性牛皮关节炎 (LO-PsA) 在老年人中显示出更高的高血压和糖尿病率,与早期发性牛皮关节炎相比,使用先进疗法较少. 针对这个不断增长的患者群体,量身定制的治疗是至关重要的.
科学领域:
- 类风湿病学 类风湿病学
- 老年病的医生 老年病的医生
- 临床流行病学临床流行病学
背景情况:
- 晚发性牛皮关节炎 (LO-PsA) 在老年人群中越来越普遍,但仍未得到充分研究.
- 了解LO-PsA的独特特征对于改善患者护理至关重要.
- 这项研究解决了关于LO-PsA临床和治疗特征的知识差距.
研究的目的:
- 为了比较LO-PsA与早期发作的PsA (EO-PsA) 的人口,临床和治疗模式.
- 确定与LO-PsA发展相关的因素.
- 为老年患有牛皮关节炎的老年人提供最佳的护理策略.
主要方法:
- 一项雄心勃勃的多中心研究,涉及横截面评估牛皮关节炎 (PsA) 患者.
- 患者被分为LO-PsA (>60岁) 或EO-PsA (≤60岁).
- 使用统计分析,包括多变量逻辑回归来比较群体并确定相关因素.
主要成果:
- 与EO-PsA (n=184) 相比,LO-PsA患者 (n=87) 的高血压率 (50%对21.4%) 和糖尿病率 (22.1%对7.9%) 显着更高.
- 在LO-PsA中,橄关节呈现更为常见 (57.4%与40.5%相比).
- LO-PsA患者接受生物/向合成疾病修饰性抗风湿药物 (b/tsDMARDs) 的频率较低 (42.6%对58.7%).
- 在多变量分析中,高血压和糖尿病与LO-PsA独立相关.
结论:
- LO-PsA的特点是具有独特的临床特征,并具有更高的并发病负担,特别是高血压和糖尿病.
- 患有PsA的老年人不太可能接受像b/tsDMARDs这样的先进疗法.
- 这些发现强调了为LO-PsA患者开发量身定制的管理方法的必要性.
相关概念视频
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
37
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
37
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
66
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
66
Rheumatic Heart Disease III: Medical Management
35
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
35
Atherosclerosis III: Management
40
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
40
Nephrotic Syndrome II : Assessment and Medical Management
23
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
23
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K


